Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts

Athanasios Pipilis1, Sotirios Kaliambakos, Christos Xenodochidis

  • 11st Cardiology Clinic, "Hygeia" Diagnostic and Therapeutic Centre, Athens, Greece. a.pipilis@hygeia.gr

Insights

Clinical judgment aligns with cardiovascular risk guidelines for extreme cases but falters with intermediate risks. Utilizing risk charts can enhance the objectivity of preventive cardiovascular care.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Decision Making

Background:

  • Cardiovascular risk charts are crucial for managing asymptomatic individuals.
  • Physicians often make management decisions without consulting these risk assessment tools.
  • This study evaluated the accuracy of clinical judgment against established guidelines.

Purpose of the Study:

  • To quantify the extent of cardiovascular risk overestimation and underestimation in clinical practice.
  • To compare physician-based risk assessment with European Society of Cardiology guidelines.
  • To identify discrepancies in managing intermediate cardiovascular risk cases.

Main Methods:

  • Thirty primary care physicians assessed seven anonymized patient cases with varying cardiovascular risk profiles.
  • Physicians determined the need for hypolipidaemic therapy for each case.
  • Responses were compared against recommendations from European cardiovascular prevention guidelines and risk charts.

Main Results:

  • Overall agreement with guidelines was 70%, with absolute agreement in very low and very high-risk cases.
  • Agreement significantly decreased in intermediate-risk cases, particularly those with cholesterol levels between 200-240 mg/dL (40% agreement).
  • Both overestimation and underestimation of cardiovascular risk were observed in intermediate cases.

Conclusions:

  • Physician judgment aligns with guidelines for clear-cut low or high cardiovascular risk.
  • Intermediate cardiovascular risk cases show significant variability, leading to inappropriate hypolipidaemic treatment prescriptions or missed therapeutic opportunities.
  • Implementing cardiovascular risk charts in practice can promote more objective and evidence-based preventive strategies.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...